CADASIL AND CARASIL: A MUTATED HEREDITARY LEUKOENCEPHALOPATHY – NEW FINDINGS

Aim: To explore recent discoveries related to CADASIL and CARASIL, rare hereditary cerebral small vessel diseases caused by mutations, and to assess their implications for diagnosis, management, and understanding of leukoencephalopathy. Background: CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) and CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) are genetic disorders primarily affecting the brain’s small blood vessels. CADASIL results from NOTCH3 mutations, while CARASIL stems from HTRA1 mutations. Both conditions exhibit progressive neurological symptoms, including recurrent strokes, cognitive decline, and mood disturbances. Despite their similarities, CARASIL typically presents earlier and progresses faster. Limited understanding of their pathophysiology has historically impeded timely diagnosis and therapeutic advancements.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-16
DOI
https://doi.org/10.5281/zenodo.15229010
Primary Topic
Canadian Policy and Governance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CADASIL AND CARASIL: A MUTATED HEREDITARY LEUKOENCEPHALOPATHY – NEW FINDINGS

Zenodo (CERN European Organization for Nuclear Research)
Canadian Policy and Governance
article

CADASIL AND CARASIL: A MUTATED HEREDITARY LEUKOENCEPHALOPATHY – NEW FINDINGS

article en

Abstract

Aim: To explore recent discoveries related to CADASIL and CARASIL, rare hereditary cerebral small vessel diseases caused by mutations, and to assess their implications for diagnosis, management, and understanding of leukoencephalopathy. Background: CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) and CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) are genetic disorders primarily affecting the brain’s small blood vessels. CADASIL results from NOTCH3 mutations, while CARASIL stems from HTRA1 mutations. Both conditions exhibit progressive neurological symptoms, including recurrent strokes, cognitive decline, and mood disturbances. Despite their similarities, CARASIL typically presents earlier and progresses faster. Limited understanding of their pathophysiology has historically impeded timely diagnosis and therapeutic advancements.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 51%
Canadian Policy and Governance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CADASIL AND CARASIL: A MUTATED HEREDITARY LEUKOENCEPHALOPATHY – NEW FINDINGS · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS